SEC reporting owner
| Reporting owner CIK | 0001024004 |
|---|---|
| Issuers | 8 |
| Qualifying disclosures | 27 |
| Public purchases | 18 |
| Recent-window purchases | 0 |
| Recent-window sales | 0 |
| Last public filing | 2026-01-07 |
| Coverage | unverified |
| Publicly available | Trade date | Ticker | Code | Shares | Reported value |
|---|---|---|---|---|---|
| 2026-01-06 | 2026-01-02 | DRMA | A | 2,500 | Not reported |
| 2025-01-23 | 2025-01-23 | DRMA | A | 78,741 | Not reported |
| 2025-01-23 | 2025-01-21 | DRMA | A | 78,741 | Not reported |
| 2025-01-14 | 2025-01-13 | DRMA | A | 5,000 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.